Skip to main content

Call for papers - Developments in selective drug deliveries

Guest Editors:
Koushik Debnath: University of Illinois Chicago, USA
Vijayabhaskarreddy Junnuthula: University of Helsinki, Finland

Submission Status: Open   |   Submission Deadline: 5 July 2024


BMC Pharmacology and Toxicology is calling for submissions to our Collection on Developments in selective drug deliveries. We welcome research that focuses on, but is not limited to, next-generation drug delivery for diseases, novel methods of drug delivery carriers, utilization of advanced technologies for drug delivery and personalized drug delivery systems.

Meet the Guest Editors

Back to top

Koushik Debnath: University of Illinois Chicago, USA

Dr Koushik Debnath is a bio-materials scientist at the University of Illinois Chicago, specializing in the design of bio-materials for tissue regeneration. His research focuses on the development of nanomedicine for the treatment of neurodegenerative diseases. Additionally, he explores the utilization of cell-secreted extracellular vesicles for targeted cargo delivery in the context of degenerative diseases.
 

Vijayabhaskarreddy Junnuthula: University of Helsinki, Finland

Vijayabhaskarreddy Junnuthula is a grant-funded researcher at the University of Helsinki, Finland. His research prominently revolves around the development of nanomedicine, spanning various domains within Pharmaceutical Sciences, most notably Pharmaceutics, Pharmacokinetics, and Local Drug Delivery for diverse therapeutic applications. He has been supported by the Finnish Cultural Foundation and was a recipient of The Marie Curie Fellowship from the European Commission under the Horizon 2020 program.


About the Collection

BMC Pharmacology and Toxicology is calling for submissions to our Collection on Developments in selective drug deliveries. We welcome research that focuses on, but is not limited to, next-generation drug delivery for diseases, novel methods of drug delivery carriers, utilization of advanced technologies for drug delivery and personalized drug delivery systems.

Recent advancements seen in the field of drug delivery technologies have resulted in significant improvement in treatment outcomes. Reduction of adverse effects, discovery of new delivery routes and pathways, and maximization of therapeutic efficacy are the few marked improvements orchestrated by advances in drug delivery research. Hand in hand with the continually evolving therapeutic landscape, recent developments of drug discovery have encouraged the shift from small-molecule drugs to new generations of therapeutics, including proteins and peptides, monoclonal antibodies and live cells. 

Image credit: Shutterstock / Gorodenkoff

  1. Definity is an ultrasound contrast agent consisting of phospholipids-encapsulated perfluoropropane (PFP), also known as perflutren, microspheres, which is initially designed to enhance echocardiographic ultras...

    Authors: Pengfei Li, Ping Du, Jun Peng, Zhixia Zhao, Huiling Li, Weiyue Yu, Shumin Wang and Lihong Liu
    Citation: BMC Pharmacology and Toxicology 2024 25:6
    Content type: Research Published on:

  2. Nebulizers are commonly used to treat respiratory diseases, which are a major cause of morbidity and mortality. While inhalation therapy with antibodies has been evaluated in preclinical studies and clinical t...

    Authors: Soon Woo Hong, Kyung Hwa Chang, Chang Jae Woo, Ho Chul Kim, Bong Seop Kwak, Bong Joo Park and Ki Chang Nam
    Citation: BMC Pharmacology and Toxicology 2023 24:70
    Content type: Research Published on:

Submission Guidelines

Back to top

This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Developments in selective drug deliveries" from the dropdown menu.

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.